Vitamin D supplementation and COVID-19 risk: A Population-based Cohort Study
20/02/2022
Oristrell, J., Oliva, J.C., Casado, E. et al, J Endocrinol Invest 45, 167-179 (2022)
This large, population-based study observed that "Patients on cholecalciferol treatment achieving 25OHD levels ≥ 30 ng/ml had lower risk of SARSCoV2 infection, lower risk of severe COVID19 & lower COVID-19 mortality than unsupplemented 25OHD-deficient patients ..."
